Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Sulfinpyrazone is a uricosuric agent that competitively inhibits uric acid (Item No. 16219) reabsorption in kidney proximal tubules, which is a key mechanism targeted in the treatment of gout.1,2 It can also inhibit degranulation of platelets, reducing the release of ADP and thromboxane and diminishing platelet aggregation.3
WARNING This product is not for human or veterinary use.
1. Comparison of the uricosuric effect of sulfinpyrazone (anturan) and zoxazolamine (flexin). Can. Med. Assoc. J. 83, 885-888 (1960).
2. Diagnosis and management of gout. BMJ 332, 1315-1319 (2006).
3. Sulphinpyrazone metabolism during long-
Calibration and characterization of intracellular Asante Potassium Green probes, APG-